SKI Market

Indian Indices

Nifty

22,475.85 -172.35
(-0.76%)

Sensex

73,878.15 -732.96
( -0.98%)

Bank Nifty

48,923.55 -307.50
( -0.62%)

Nifty IT

32,908.40 -294.95
( -0.89%)

Global Indices

Nasdaq

16,156.33 315.37
(1.99%)

Dow Jones

38,675.68 450.02
(1.18%)

Hang Seng

18,475.92 268.79
(1.48%)

Nikkei 225

38,236.07 -37.98
(-0.10%)

Forex

USD-INR

83.43 -0.03
(-0.04%)

EUR-INR

89.37 0.26
(0.29%)

GBP-INR

104.48 0.21
(0.20%)

JPY-INR

0.54 0.01
(1.69%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Sequent Scientific Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512529

INE807F01027

42.6256986

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SEQUENT

3014.4

EPS(TTM)

Face Value()

Div & Yield %

0.06

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	222.69	219.63	265.46	227.33	166.26	107.24
Excise Duty	0.00	0.00	0.00	0.00	0.00	1.23
Net Sales	222.69	219.63	265.46	227.33	166.26	106.01
Other Income	28.24	27.64	19.97	14.56	13.96	432.88
Stock Adjustments	-19.42	19.73	15.56	3.89	2.95	0.42
Total Income	231.51	267.00	300.99	245.78	183.17	539.31
EXPENDITURE :
Raw Materials	116.50	128.39	124.43	116.93	97.57	79.80
Power & Fuel Cost	13.93	11.96	12.77	12.74	8.52	2.32
Employee Cost	36.66	27.38	22.42	17.10	10.71	11.85
Other Manufacturing Expenses	43.24	52.53	57.73	50.56	39.93	15.36
Selling & Administrative Expenses	17.79	19.40	20.27	9.98	8.36	12.13
Miscellaneous Expenses	1.52	0.45	10.68	1.68	1.43	4.52
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	229.63	240.11	248.29	208.98	166.52	125.98
Operating Profit	1.88	26.89	52.70	36.80	16.64	413.33
Interest	2.51	1.61	2.68	5.04	3.22	0.39
Gross Profit	-0.63	25.28	50.02	31.76	13.42	412.94
Depreciation	9.12	9.59	9.13	8.95	7.22	3.67
Profit Before Tax	-9.75	15.69	40.89	22.81	6.20	409.27
Tax	-0.57	0.37	6.09	3.18	-0.05	2.87
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-3.09	0.52	2.69	-1.71	-1.33	0.00
Reported Net Profit	-6.08	14.80	32.11	21.34	7.59	406.41
Extraordinary Items	0.00	0.00	-0.75	0.00	0.00	2.81
Adjusted Net Profit	-6.08	14.80	32.86	21.34	7.59	403.60
Adjustment below Net Profit	0.09	0.07	43.38	-1.30	0.32	-391.91
P & L Balance brought forward	30.56	28.03	-47.47	-62.65	-70.55	-79.21
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	-14.18	12.34	0.00	4.86	0.00	5.84
P & L Balance carried down	38.76	30.56	28.03	-47.47	-62.65	-70.55
Dividend	0.00	0.00	0.00	0.00	0.00	4.85
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	25.00	0.00	10.00	10.00
Dividend Per Share(Rs)	0.00	0.00	0.50	0.00	0.20	0.20
Earnings Per Share-Unit Curr	-0.24	0.60	1.29	0.86	0.31	16.67
Earnings Per Share(Adj)-Unit Curr	-0.24	0.60	1.29	0.86	0.31	15.40
Book Value-Unit Curr	42.43	41.55	41.45	35.68	37.18	38.92
Book Value(Adj)-Unit Curr	42.43	41.55	41.45	35.68	37.18	35.96

22,475.85 -172.35 (-0.76%)

73,878.15 -732.96 ( -0.98%)

48,923.55 -307.50 ( -0.62%)

32,908.40 -294.95 ( -0.89%)

16,156.33 315.37 (1.99%)

38,675.68 450.02 (1.18%)

18,475.92 268.79 (1.48%)

38,236.07 -37.98 (-0.10%)

83.43 -0.03 (-0.04%)

89.37 0.26 (0.29%)

104.48 0.21 (0.20%)

0.54 0.01 (1.69%)